This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Forwardvue Pharma, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Srikanth Kakamanu and His Work on CAI Nanoemulsions.
Introduction
Srikanth Kakamanu is an inventor associated with Mobile, Alabama, and Forwardvue Pharma, Inc. His patent work concerns a formulation of carboxy-amido-triazole, or CAI, for potential use in treating inflammatory optic neuropathies.
Latest Patents
Kakamanu is associated with 1 patent, titled “CAI Nanoemulsions.” The disclosure describes nanoemulsions containing 5-amino-[4-(4-chlorobenzoyl)-3,5-dichlorobenzyl]-1,2,3-triazole-4-carboxamide, methods for preparing them, and their use in treating inflammatory optic neuropathies.
Career Highlights
His listed work connects pharmaceutical formulation research with the development of nanoemulsion delivery approaches. The patent disclosure focuses on preparing CAI in a formulation intended for therapeutic applications.
Collaborations
Kakamanu’s listed coworkers include Alan J. Franklin and Laurent Balenci. Their names are associated with the professional and patent context provided for his work at Forwardvue Pharma, Inc.
Conclusion
Srikanth Kakamanu’s patent activity centers on CAI nanoemulsions and their potential application in treating inflammatory optic neuropathies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile